Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
4.510
-0.200 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Galecto Market Cap
Galecto has a market cap or net worth of $5.94 million as of February 21, 2025. Its market cap has decreased by -63.40% in one year.
Market Cap
5.94M
Enterprise Value
-13.71M
1-Year Change
-63.40%
Ranking
Category
Stock Price
$4.51
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $5.94M, a decrease of -98.39%. That is a compound annual growth rate of -61.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 5.94M | -3.01% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |